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Over the last decade, mouse models have become a popular instrument for studying
cardiac arrhythmias. This review assesses in which respects a mouse heart is a miniature
human heart, a suitable model for studying mechanisms of cardiac arrhythmias in humans
and in which respects human and murine hearts differ. Section I considers the issue of
scaling of mammalian cardiac (electro) physiology to body mass. Then, we summarize
differences between mice and humans in cardiac activation (section II) and the currents
underlying the action potential in the murine working myocardium (section III). Changes in
cardiac electrophysiology in mouse models of heart disease are briefly outlined in section
IV, while section V discusses technical considerations pertaining to recording cardiac
electrical activity in mice. Finally, section VI offers general considerations on the influence
of cardiac size on the mechanisms of tachy-arrhythmias.
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SCALING OF CARDIAC PHYSIOLOGY TO BODYMASS
Body mass varies between small mammals like the mouse
(0.03 kg, see Table 1) to the largest mammal, the blue whale
(30,000 kg) by a factor of 106 (Noujaim et al., 2004). Very diverse
physiological parameter such as basal metabolic rate, life span,
left ventricular ejection time, and ECG time intervals (RR, PR,
QRS, and QT) scale with body mass (BM) (West et al., 1997,
1999; Noujaim et al., 2004, 2007; Popovic et al., 2005). The “uni-
versal law of allometric scaling” for a parameter P is expressed
by the allometric equation: P = aBMb (West et al., 1997, 1999;
Noujaim et al., 2007), where a is a normalization constant and
b represents the scaling exponent. Frequently, b is a multiple
of 1/4. Basal metabolic rate scales as BM3/4 (West et al., 1997,
1999) and is thought to be related to the ratio of body sur-
face area to body volume. A larger body surface-to-volume ratio
results in faster temperature loss of the body and thus requires a
higher basal metabolic rate to maintain body temperature. Mice,
with a high surface-to-volume ratio, tend to have a relatively
high basal metabolic rate (see Table 1). Adequate blood pres-
sure is required to maintain homeostasis and basal metabolic
rate. The mean arterial pressure does not scale with body mass
and is thus similar between mice and humans (West et al., 1997;
Janssen and Smits, 2002). By contrast, cardiac output (CO, expo-
nent 3/4), cardiac stroke volume (SV, exponent 1), blood volume
(exponent 1) and circulation time (exponent 1/4) (West et al.,
1997; Janssen and Smits, 2002) scale with BM. In mice, CO
amounts to 0.0085–0.027 L/min (Table 1) and thus the murine
blood volume of 0.002–0.003 L can circulate around 3–14 times
per minute. Humans have a CO of 4–8 L/min and a blood vol-
ume of 4.5–5.5 L (Table 1), which circulates circa 1–2 times per
minute. The cardiac index (CI) relates (CO = SV∗HR) to body
surface area (CI = CO/body surface area). This hemodynamic
parameter represents cardiac performance normalized to body
surface area and thus indirectly to basal metabolic rate. The car-
diac index is tenfold higher in mice than in humans (Janssen and
Smits, 2002), reflecting a higher basal metabolic rate in mice.
Normalized SV is similar between mice and humans at around
1μl/g body weight. Therefore, the difference in HR is mainly
responsible for differences in CI.
Over the entire range of BM formmice to whales, cardiac mass
amounts 0.6% of body mass (Prothero, 1979) and cardiac gross
anatomy is remarkably similar, with comparable pacemaking and
conduction structures (Wessels and Sedmera, 2003). Using the
same biochemical processes to ensure optimal electromechanical
function, hearts of very different sizes have to maintain sufficient
cardiac function under a variety of conditions. Resting heart rates
in conscious mice (measured by telemetry) range from 550 to 725
beats per minute (bpm) (Kass et al., 1998; Gehrmann et al., 2000;
Janssen and Smits, 2002; Fabritz et al., 2010), corresponding to a
sinus cycle length (SCL) of 80–110ms. Because cardiac conduc-
tion velocities are not strongly dependent on BM (Table 1 and
Figure 1), the timing intervals of the ECG scale with the prop-
agation distance, i.e., cardiac size. The ECG time intervals RR,
PR, QRS, and QT scale with BM1/4 (Noujaim et al., 2004, 2007)
and consequently heart rate scales with body mass with an expo-
nent of -1/4 (West et al., 1997; Janssen and Smits, 2002; Noujaim
et al., 2004). The PR interval represents electrical conduction
from the atrium through the AV node and His-Purkinje system to
the ventricles and thus can be seen as a fractal network with three
separate components, the PA, AH, and HV subintervals, that also
scale with body mass with an exponent of 1/4 (Noujaim et al.,
2004). Hence, percentage of each subinterval to the PR interval is
constant and independent of body and heart size (Noujaim et al.,
2004).
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Table 1 | Comparison of mouse and human (cardiac) physiology.
Human References Mouse References
GENERAL
Body mass (kg) 58–85 de la Grandmaison et al., 2001; Stein
et al., 2002; Noujaim et al., 2004;
Johnstone et al., 2005; Kasper et al.,
2008; Later et al., 2010; Barnes et al.,
2012
0.015–0.043 Sheng et al., 1999; Verheule et al., 1999; VanderBrink
et al., 2000; Janssen and Smits, 2002; Speakman
et al., 2002; Noujaim et al., 2004; Xiao et al., 2004;
Muller et al., 2005; Hong et al., 2008; Barwe et al.,
2009; Brands et al., 2010; Carlstrom et al., 2010; Gros
et al., 2010; Carroll et al., 2011
Lifespan (year) 70–80 Zhang and Zhang, 2009 2–2.5 Speakman et al., 2002; Zhang and Zhang, 2009
Basal metabolic rate (kJ/d) 6279 Johnstone et al., 2005 15.6 Speakman et al., 2002
Basal metabolic rate (O2
consumption L/(kg*h)
0.9 Janssen and Smits, 2002 0.8–3 Desai et al., 1997; Janssen and Smits, 2002
HEART
Heart weight (g) 261–366 de la Grandmaison et al., 2001; Cunha
et al., 2002; Janssen and Smits, 2002;
Later et al., 2010
0.12–0.17 Muller et al., 2005; Hong et al., 2008; Barwe et al.,
2009; Carlstrom et al., 2010; Carroll et al., 2011
Heart weight/body weight
ratio (kg/kg)
0.004–0.006 de la Grandmaison et al., 2001; Cunha
et al., 2002; Later et al., 2010
0.004–0.005 Muller et al., 2005; Hong et al., 2008; Barwe et al.,
2009; Carlstrom et al., 2010; Carroll et al., 2011
HEMODYNAMIC
Stroke volume (mL) 50–100 Janssen and Smits, 2002; Meijler et al.,
2005; Kasper et al., 2008
0.015–0.05 Janssen and Smits, 2002; Fabritz et al., 2010; Gros
et al., 2010; Hyyti et al., 2010; Maslov et al., 2010
Cardiac output (L/min) 4–8 Janssen and Smits, 2002; Mestas and
Hughes, 2004; Meijler et al., 2005;
Kasper et al., 2008
0.005–0.03 Janssen and Smits, 2002; Mestas and Hughes, 2004;
Gros et al., 2010; Maslov et al., 2010
Blood pressure (mean
arterial pressure, mmHg)
88–100 Mancia et al., 1983; Janssen and Smits,
2002; Barnes et al., 2012; Damkjaer
et al., 2012
73–125 Kass et al., 1998; Sheng et al., 1999; Janssen and
Smits, 2002; Brands et al., 2010; Carlstrom et al., 2010
Blood volume (L) 5–6 Janssen and Smits, 2002; Mestas and
Hughes, 2004; Kasper et al., 2008
0.002–0.03 Sheng et al., 1999; Janssen and Smits, 2002; Mestas
and Hughes, 2004
CARDIAC EP
Heart rate (beats/min) 56–101 Edvardsson et al., 1984; Franz et al.,
1987; Janssen and Smits, 2002; Stein
et al., 2002; Noujaim et al., 2004;
Monnig et al., 2005; Zhang and Zhang,
2009; Barnes et al., 2012; Rich et al.,
2012
500–724 Kass et al., 1998; Gehrmann et al., 2000; Janssen and
Smits, 2002; Xiao et al., 2004; Fabritz et al., 2010
PR interval (ms) 120–200 Stein et al., 2002; Waldek, 2003;
Noujaim et al., 2004; Kasper et al.,
2008; Grecu et al., 2009
30–56 Thomas et al., 1998; Jalife et al., 1999; Morley et al.,
1999; Vaidya et al., 1999; VanderBrink et al., 1999,
2000; Verheule et al., 1999; Gehrmann et al., 2000;
Maguire et al., 2000; Saba et al., 2000; Tamaddon
et al., 2000; Wehrens et al., 2000; Li et al., 2004,
2009; Noujaim et al., 2004; Saba et al., 2005; Zhang
et al., 2005; Sawaya et al., 2007; Mancarella et al.,
2008; Stein et al., 2009
QRS duration (ms) 84–110 Kasper et al., 2008; Grecu et al., 2009;
Rich et al., 2012
9–30 Thomas et al., 1998; Jalife et al., 1999; Morley et al.,
1999; Vaidya et al., 1999; VanderBrink et al., 1999,
2000; Verheule et al., 1999; Gehrmann et al., 2000;
Maguire et al., 2000; Saba et al., 2000; Tamaddon
et al., 2000; Wehrens et al., 2000; Schrickel et al.,
2002; Alcolea et al., 2004; Xiao et al., 2004; Saba
et al., 2005; Sawaya et al., 2007; Schrickel et al.,
2007; Stein et al., 2009; Gros et al., 2010
QT (ms) 385 Rich et al., 2012 29–109 Thomas et al., 1998; Jalife et al., 1999; Morley et al.,
1999; Vaidya et al., 1999; VanderBrink et al., 1999;
Gehrmann et al., 2000; Maguire et al., 2000; Saba
et al., 2000; VanderBrink et al., 2000;
(Continued)
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Table 1 | Continued.
Human References Mouse References
Wehrens et al., 2000; Schrickel et al., 2002; Li
et al., 2004; Xiao et al., 2004; Saba et al., 2005;
Schrickel et al., 2007; Fabritz et al., 2010; Gros
et al., 2010
QTc (ms) 398–430 Stein et al., 2002; Rich et al., 2012 30–124 Gehrmann et al., 2000; Maguire et al., 2000; Saba
et al., 2000; Schrickel et al., 2002, 2007; Li et al.,
2004; Zhang et al., 2005; Sawaya et al., 2007;
Stein et al., 2009; Gros et al., 2010
Atrial ERP (ms) 172–245 Chiamvimonvat et al., 1998; Schauerte
et al., 2001; Dorian et al., 2007;
Roberts-Thomson et al., 2009; Stiles
et al., 2010
23–71 Thomas et al., 1998; VanderBrink et al., 1999;
Verheule et al., 1999; van Veen et al., 2005; Zhang
et al., 2005; Sawaya et al., 2007; Schrickel et al.,
2007; Li et al., 2009; Odening et al., 2009
Atrial CV (cm/s) 88 Hansson et al., 1998 30–60 Thomas et al., 1998; Verheule et al., 1999; Alcolea
et al., 2004; van Veen et al., 2005
AV Wenckebach CL (ms) 329–453 Chiamvimonvat et al., 1998; Schauerte
et al., 2001; Stein et al., 2002; Kose
et al., 2004; Dorian et al., 2007; Grecu
et al., 2009
66–133 Thomas et al., 1998; Hagendorff et al., 1999;
VanderBrink et al., 1999; Verheule et al., 1999;
Maguire et al., 2000; Saba et al., 2000;
VanderBrink et al., 2000; Korte et al., 2002;
Schrickel et al., 2002; Saba et al., 2005; Zhang
et al., 2005; Sawaya et al., 2007; Schrickel et al.,
2007; Li et al., 2009; Blana et al., 2010
Ventricular ERP (ms) 223–257 Edvardsson et al., 1984;
Chiamvimonvat et al., 1998; Schauerte
et al., 2001; Dorian et al., 2007
33–80 Thomas et al., 1998; Verheule et al., 1999; Kovoor
et al., 2001; Korte et al., 2002; Saba et al., 2005;
van Veen et al., 2005; Zhang et al., 2005; Sawaya
et al., 2007; Schrickel et al., 2007; Li et al., 2009;
Stein et al., 2009
Ventricular CV (cm/s) 80 de Bakker et al., 1993 30–60 Thomas et al., 1998; Morley et al., 1999; Alcolea
et al., 2004; van Veen et al., 2005
FIGURE 1 | Comparison of the human and murine ECG, 2-s traces showing lead I. Inset shows a single complex from the mouse ECG (human ECG is
patient 121 in the PTB database at www.physionet.org, mouse ECG courtesy of Dr. Ricardo Carnicer, Oxford University).
Mice can increase their HR by around 30–40% (Vornanen,
1992; Kass et al., 1998; Fabritz et al., 2010), whereas humans
HR can increase by 300%. Thus, an increase in frequency can
contribute far less to increase cardiac output (CO) in mice than
in humans. The ratio of maximal to resting heart rate scales to
BM with the following equation HRmax/HRrest = 1.87 × BM−0.1
(Kass et al., 1998). Actin-myosin crossbridge kinetics have an
estimated maximal rate of around 1000 bpm, corresponding to
a cycle length (CL) of 60ms (Kass et al., 1998). Maximal heart
rates observed in mice are in a range of 725–815 bpm (Vornanen,
1992; Kass et al., 1998; Fabritz et al., 2010). Thus, an increase in
murine HR is limited as the maximal HR is close to the maximal
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actin-myosin crossbridge frequency. In addition, studies in mice
have found an AV Wenckebach period of 66–103ms (Table 1).
With an increase in HR, this Wenckebach period is reached rel-
atively quickly, also limiting the increase in CO. For efficient
cardiac pump function and CO, optimal timing of AV conduc-
tion is required. Late diastolic left ventricular filing time scales
with heart length and with an 1/3 exponent to cardiac or body
mass, whereas AV delay scales with an ¼ exponent of heart or
body mass (Noujaim et al., 2004; Meijler et al., 2005). In mice,
an increase in heart rate decreases diastolic left ventricular filing
time and thus gradually reduces ventricular end-diastolic volume.
Finally, mice at physiological HR have a small force-frequency
reserve compared to humans (Georgakopoulos and Kass, 2001).
Consequently, ventricular filing is limited at high heart rates in
mice, further impeding CO enhancement and cardiac contractil-
ity. Taken together, these factors explain why mice can raise their
CO only over a small range, whereas humans can increase their
CO by a factor 5–6. This difference should be taken into account
when HR regulation (e.g., during exercise) is relevant.
CARDIAC ACTIVATION IN MICE
SINOATRIAL NODE
The lateral and medial limb of the crista terminalis at the ori-
fice of the superior caval vein frame the murine SA node region
(Verheijck et al., 2001; Mommersteeg et al., 2007). During devel-
opment, the SA is node is distinguished from the adjacent atrial
myocardium by the absence of the transcription factor Nkx2.5
and the presence of the transcription factors Tbx3 and Tbx18,
both in humans andmice (Christoffels et al., 2006; Mommersteeg
et al., 2007; Sizarov et al., 2011). These differences in transcrip-
tion factor profiles initiate diverging gene expression programs,
leading to differences in e.g., connexin and ion channel expres-
sion (Hoogaars et al., 2007). Histologically, the SA node consists
of a large head and a smaller tail along the crista terminalis
(Wiese et al., 2009). Characteristic sinus node APs (a marked
diastolic depolarization and low upstroke velocity) are found in
a region 300μm in parallel and 150μm perpendicular to the
crista terminalis (Opthof, 2001; Verheijck et al., 2001). A mor-
phologically “nodal” cell type is present in a somewhat larger
region 500μm parallel to the crista (Opthof, 2001; Verheijck
et al., 2001). Surprisingly, Glukhov et al. have shown that in the
mouse, the location of the dominant pacemaker can shift during
(para)sympathomimetic treatment within a still larger region of
approximately 5 × 2mm between the superior and inferior caval
veins (Glukhov et al., 2010).
The sinoatrial conduction time, defined as the conduction
time from the primary, dominant sinus node cells to atrial
myocardium is 4–5ms and the transition from a nodal to an atrial
AP morphology takes place over a very short distance of about
100μm (Opthof, 2001; Verheijck et al., 2001).
SA nodal APs in mice have an amplitude, maximum diastolic
potential and upstroke velocity comparable to those in humans,
but a much shorter APD, probably due to differences in delayed
rectifier currents (Opthof, 2001). The SCN5A encoded cardiac
Nav1.5 sodium channel affects SA node pacemaker function, as
heterozygous deletion of the SCN5A gene in mice caused sinus
bradycardia and exit block (Lei et al., 2005). Similarly, sinus
bradycardia and sinus pauses are prevalent in LQT3 patients
with certain SCN5Amutations (Veldkamp et al., 2003). However,
SCN5A-related alterations in sinus node function may be caused
by the involvement of Nav1.5 in extracellular matrix remodel-
ing, rather than a primary electrical effect (Hao et al., 2011). The
α1D form of the L-type Ca2+ channel is expressed in the SA node
and contributes to diastolic depolarization and pacemaker activ-
ity, and deletion of this gene leads to sinus bradycardia (Zhang
et al., 2002; Mangoni et al., 2003; Qu et al., 2005).
The murine SA node expresses hyperpolarization-activated,
nonselective cation channels from the HCN family. HCN4 is
the dominant isoform, although smaller amounts of HCN1 and
HCN2 are also expressed (Liu et al., 2007; Ludwig et al., 2008;
Herrmann et al., 2011). Specific mutations in the HCN4 gene
can cause bradycardia in humans (Milanesi et al., 2006). HCN4
knock-out mice have produced diverging results (Herrmann
et al., 2012). Mice with conditional ubiquitous HCN4 deletion
in the adult stage were not bradycardic, even at less than 10% of
normal HCN4 levels, but did show sinus pauses that were activ-
ity dependent and more prevalent at low heart rates (Herrmann
et al., 2007; Hoesl et al., 2008). If in isolated SA nodal cells
from these mice was decreased by 75% and these cells often did
not show pacemaker activity under baseline conditions, but did
become spontaneously active in response to adrenergic stimu-
lation (Herrmann et al., 2007; Ludwig et al., 2008). However,
another mouse model with heart-specific conditional deletion of
HCN4 did show profound sinus bradycardia (Baruscotti et al.,
2011). HCN2 deficient mice have a sinus dysarrhythmia lead-
ing to a marked increase in RR variability, although the response
to adrenergic and cholinergic stimulation was preserved (Ludwig
et al., 2003).
In mice, Cx45 is expressed in SA node center (Opthof, 2001;
Verheijck et al., 2001). On the epicardial side, the murine SA
node is entered by strands of cells expressing Cx40 and Cx43
(Verheijck et al., 2001). Also in humans, atrial myocardial cells
with Cx43 expression protrude into the Cx43 negative SA nodal
area (Oosthoek et al., 1993). The murine SA node architecture
containing different types of gap junctions and connective tis-
sue around the nodal area are hypothesized to shield the SA
node against hyperpolarizing influence of surrounding atrial
myocardium and thus to allow pacemaker activity and conduc-
tion from the SA node to atrial myocardium (Verheijck et al.,
2001).
ATRIAL ACTIVATION
Various studies have shown atrial conduction patterns in mice.
Atrial activation starts near the expected location of the sinoa-
trial node close to the superior vena cava and from there spreads
rapidly over the right and left atria (Leaf et al., 2008; Mathur et al.,
2009; Blana et al., 2010; Kirchhof et al., 2011; Swaminathan et al.,
2011). It is not clear whether mice have a true Bachmann’s bun-
dle, which in larger species is a thick, highly anisotropic structure
consisting of many parallel fibers, serving as the largest and fastest
conduction pathway between the atria. The total atrial conduc-
tion time amounts to approximately 15ms (Blana et al., 2010;
Swaminathan et al., 2011). The atria express both Cx40 and Cx43.
The specific role of Cx40 is unclear, with observations in Cx40−/−
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mice ranging from a reduced CV (Verheule et al., 1999) to a
reduced conduction heterogeneity without a change in CV (Leaf
et al., 2008). The atrial ERP shows little rate-dependence and in
some cases it may be longer than the AV nodal ERP (Etzion et al.,
2008).
ATRIOVENTRICULARNODE
The murine AV node has similar properties to the human AV
node (VanderBrink et al., 1999). In some humans, the AV node
shows “dual AV physiology” with a distinct slow and fast path-
way, giving rise to a discontinuous AV conduction curve during
premature atrial stimulation. The prevalence of dual AV nodal
physiology increases during postnatal development and around
40% of adult humans display dual AV nodal physiology (Denes
et al., 1973; Thapar and Gillette, 1979; Cohen et al., 1997). A
maturation study in mice demonstrated that dual AV nodal phys-
iology and AV nodal echo beats also become more frequent
with increasing age, but without inducibility of AV nodal reen-
try tachycardia (Maguire et al., 2000). In contrast, another study
of the murine AV node did not find dual AV nodal physiology
(VanderBrink et al., 1999). As in larger species, the AV node shows
“facilitation” during an acceleration in rate, and this property is
lost in Cx40 deficient mice (Zhu et al., 2005).
The areas bordering the AV node show a complex profile
of Cx expression, which has been studied in mice and humans
(Aanhaanen et al., 2010; Greener et al., 2011). Myocytes in the
compact node, the area responsible for the major part of the AV
delay, express Cx40 and Cx45 in both mice and humans. In addi-
tion, Cx30.2 is expressed in mice, but its orthologue Cx31.9 is not
present in the human AV node. In Cx40+/− mice and Cx45+/−
mice, AV conduction is not affected (Hagendorff et al., 1999;
Verheule et al., 1999; Kruger et al., 2006). The AV delay increases
in Cx40−/− mice (Hagendorff et al., 1999; Verheule et al., 1999)
and increases further in Cx40−/−Cx45+/− mice (Kruger et al.,
2006), indicating that both connexins contribute to AV conduc-
tion. Intriguingly, the AV delay is shorter in Cx30.2−/− mice
and normal in Cx30.2−/−Cx40−/− mice (Kreuzberg et al., 2006;
Schrickel et al., 2009). Thus, Cx30.2 may represent an arrange-
ment to decelerate AV nodal conduction that is specific to mice.
In humans, the homeobox transcription factor Nkx2-5 is
expressed in the AV node and heterozygous mutations caused
congenital atrioventricular conduction abnormalities, e.g., AV
block (Schott et al., 1998). A murine model with a heterozygous
Nkx2-5 mutation has a hypoplastic AV node (Jay et al., 2004).
Furthermore, overexpression of a human mutation of Nkx2-5 in
transgenic mice led to heart failure and progressive AV conduc-
tion defects, possibly due to reduced Cx40 and Cx43 expression
(Kasahara et al., 2001). Similarly, haploinsuffiency in mice of the
transcription factor Tbx5, which has a synergystic effect with
Nkx2-5 on gene transcription, causes abnormalities similar to
those in the human Holt-Oram syndrome, including decreased
Cx40 expression and AV block (Bruneau et al., 2001; Moskowitz
et al., 2007).
VENTRICULAR ACTIVATION AND REPOLARIZATION
The ventricular conduction system lineage is established during
development by expression of the transcription factors Nkx2-5
and Tbx5, (Jay et al., 2004; Moskowitz et al., 2007) activating a
gene program that includes Cx40, the major gap junction protein
in the His bundle and proximal conduction system. Deletion of
Cx40 leads to conduction slowing in the ventricular conduction
system (Simon et al., 1998; Bevilacqua et al., 2000; VanderBrink
et al., 2000). The murine left bundle branch is thicker than the
right bundle branch, as evidenced by Cx40 expression patterns
(van Rijen et al., 2001). This is supported by studies that suggested
that the left bundle brunch contains more parallel fibers and thus
probably has a higher conduction reserve than the right bundle
branch, possibly explaining why the right bundle branch is more
prone to conduction block (Alcolea et al., 2004). Similarly, clinical
studies tend to show a higher prevalence of conduction block in
the right bundle branch than in the left bundle branch (Tuzcu
et al., 1990; Newby et al., 1996; Golshayan et al., 1998).
The activation pattern of ventricular myocardium differs
between mice and humans. In mice, on study has reported
that ventricular epicardial activation starts with clearly defined
breakthroughs in the right ventricle and subsequently in the left
ventricle (Tamaddon et al., 2000). Another study has shown a
first breakthrough at the left ventricular apex, followed shortly
by a right ventricular breakthrough (Nygren et al., 2000). By
contrast, studies in humans found first depolarization at the left
ventricular side of the interventricular septum, conducted by sep-
tal left bundle branch fibers and corresponding to the Q wave in
the ECG (Durrer et al., 1970). Septal right bundle branch fibers
cause subsequent right ventricular activation (Durrer et al., 1970).
Within the interventricular septum, mice show an activation pat-
tern from base to apex, probably due to an electrical connection
from the common bundle into the ventricular septum (van Rijen
et al., 2001). By contrast, humans show intraventricular septal
activation from left to right and from apex to base (Durrer et al.,
1970). Conduction velocity is slower in the midseptal than in the
proximal region of the murine bundle branches, due to regional
differences in bundle geometry and connexin expression (van
Veen et al., 2005). During murine intrauterine development, the
epicardial ventricular activation pattern switches from basico-
apical to apico-basal, in correspondence with maturation of the
conduction system (Rentschler et al., 2001; Gourdie et al., 2003).
Within the mouse ventricles, repolarization is earlier in the
epicardium than in the endocardium due to a shorter epicar-
dial action potential (Knollmann et al., 2001), and earlier at the
apex than at the base (Killeen et al., 2007b; London et al., 2007).
Transmural and apico-basal gradients in Ito are thought to be
the main determinant of heterogeneity of the murine ventricular
APD (Rossow et al., 2006; Wang et al., 2006; Killeen et al., 2007b;
London et al., 2007).
Cx43 is the main gap junction protein in the ventricular
working myocardium, but its expression can be decreased by
∼80% before a marked decrease in CV and increase in vul-
nerability to arrhythmias becomes apparent (Danik et al., 2004;
van Rijen et al., 2004), as would be expected based on mathe-
matical models (Shaw and Rudy, 1997). However, more mod-
est reductions in gap junctional coupling may have significant
effects when they occur in conjunction with other factors such as
reduced excitability or fibrosis (van Veen et al., 2005; Stein et al.,
2009). Similar conjunctions of disease processes are common in
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human pathology, but poorly represented by monogenic mouse
models.
ARRHYTHMIAS LINKED TO ABNORMAL CARDIAC DEVELOPMENT
Some studies have linked human arrhythmias to gene pro-
grams active during prenatal cardiac development. The develop-
ing mouse heart contains muscular atrioventricular connections
over the annulus fibrosus (Rentschler et al., 2001). Persistence of
these connecting fibers bypass the AV node and cause ventric-
ular pre-excitation syndromes similar to Wolff-Parkinson-White
syndrome (Rentschler et al., 2001) Patients suffering from Wolff-
Parkinson-White syndrome showed mutations in the PRKAG2
gene, which encodes the gamma-2 subunit of the AMP-activated
protein kinase (Blair et al., 2001; Gollob et al., 2001). In mice,
overexpression of one of the human mutations of the PRKAG2
gene caused ventricular preexcitation and an altered annulus
fibrosis structure, disrupted by glycogen-filled myocytes that may
function as accessory pathways (Arad et al., 2003). Similarly,
inactivation of Tbx2, a transcription factor involved in the devel-
opment of the atrioventricular canal, leads to malformation of
the annulus fibrosis and ventricular preexcitation (Aanhaanen
et al., 2011). Mutations in Tbx3 are linked to ulnar-mammary
syndrome in humans. In mice, a reduction in Tbx3 activity leads
to SA node dysfunction, AV block and ventricular preexcitation
(Frank et al., 2012).
Gittenberger-de Groot and co-workers have presented exten-
sive evidence for the relationship between nodal pacemaker
tissue and the myocardial sleeves in the developing embryo
(Douglas et al., 2011) For example, podoplanin is a myocar-
dial marker expressed in cells of the developing pacemaking
system, which later differentiate e.g., to the sinoatrial node
(SA node) and atrioventricular node (AV node) (Gittenberger-
de Groot et al., 2007). Podoplanin expression is also present
in surrounding myocardium of the common pulmonary vein
(PV) (Gittenberger-de Groot et al., 2007), an area that can later
become important in the genesis of atrial fibrillation in humans
(Haissaguerre et al., 1998). These embryological relationships
have been proposed account for ectopic activity in the myocardial
sleeves of the pulmonary veins (Jongbloed et al., 2004). However,
the sinus node originates from a different type of cardiac pre-
cursor cells (i.e., Tbx18-positive and Nkx2.5-negative) than the
PV myocardium (Christoffels et al., 2006). In addition, a nodal
phenotype would be more likely to give rise to relatively slow,
gradually appearing and disappearing pacemaking activity, as has
been described in guinea pig pulmonary veins (Cheung, 1981).
By contrast, human PVs show paroxysms of arrhythmic activity
that initiate and terminate suddenly, with very rapid rates that
are more compatible with triggered activity or microreentry than
with a pacemaking activity in a latent nodal region (Haissaguerre
et al., 1998).
CARDIAC CELLULAR ELECTROPHYSIOLOGY
In general, the duration of cardiac action potentials increases with
body size and is approximately 50ms in mouse ventricles (Danik
et al., 2002), compared to 250ms in humans (Edvardsson et al.,
1984). The morphology of the action potential reflects the contri-
bution of numerous depolarizing and repolarizing currents. Even
when the same type of ion channel is expressed in human and
mice, its contribution to the morphology of the action potential
may differ substantially, given the large difference in APD. Both
in mice and humans, the refractory period ends before complete
repolarization of the AP (Knollmann et al., 2001; Fabritz et al.,
2003; Sabir et al., 2007a,b). Based on recordings of monophasic
action potentials, the ERP in mouse ventricles corresponds to the
APD80 (Knollmann et al., 2001).
Murine and human ventricular APs are both characterized
by a fast depolarizing phase (phase 0), the AP upstroke, which
is generated by the large, rapidly activating sodium current INa
(Nerbonne, 2004). The subsequent repolarization phase is a del-
icate balance of several depolarizing currents (ICaL, INCX) and
repolarizing potassium currents. In the human ventricle, a fast
repolarizing phase (phase 1) is followed by the action poten-
tial plateau (phase 2) (Nerbonne, 2004). In the mouse heart,
the L-type Ca2+ current (ICaL) contributes less to the ventric-
ular AP than in humans (Sabir et al., 2008) and therefore the
murine AP shows a gradual repolarization rather than a distinct
plateau phase. In the mouse ventricles, α1C channels are primar-
ily responsible for ICaL. By contrast, the ICaL of supraventricular
myocardium consists of both α1C and α1D Ca2+ channels (Zhang
et al., 2005; Mancarella et al., 2008; Zhang et al., 2011). The α1D
Ca2+ channel makes a significant contribution to Ca2+ influx
and Ca2+ induced Ca2+ release from the SR in atrial myocytes
(Mancarella et al., 2008).
In humans, the plateau phase ends when the balance shifts
from INCX and the slowly inactivating ICaL to slowly activat-
ing potassium currents, giving rise to the final repolarization
(phase 3) until the resting potential (phase 4) is restored. In the
human ventricle, the rapid and slow delayed outward rectifier K+
currents (IKr and IKs) are predominantly responsible for phase 3
repolarization (Li et al., 1996). In contrast, the much faster repo-
larization in mice ventricles is mediated by transient outward K+
currents with a fast and slow recovery from inactivation (Ito,f and
Ito,s), a slowly inactivating K+ current (IK,slow1 and IK,slow2) and
a non-inactivating, steady state current (Iss) (Guo et al., 1999;
Xu et al., 1999; Zhou et al., 2003; Brouillette et al., 2004; Sabir
et al., 2008). In humans, the Ito,f current is mainly involved in
phase 1 repolarization, with more prominent expression in the
epicardium (Nerbonne, 2004). In mice, Ito,f is expressed through-
out the left and right ventricles, whereas Ito,s is confined to the
septal myocardium (Xu et al., 1999). The equivalents of murine Iss
and IKslow have not been detected in human ventricles (Sabir et al.,
2008). Studies in mice did observe the rapid and slow delayed
rectifier K+ currents (IKr and IKs), but their contribution to repo-
larization under physiological conditions is probably negligible
or minor (Babij et al., 1998; Drici et al., 1998; Balasubramaniam
et al., 2003; Nerbonne, 2004; Salama et al., 2009). In the ventri-
cles of mice and humans, the inwardly rectifying K+ channel (IK1)
plays a similar role in stabilizing the resting membrane potential
and determining terminal repolarization (Babenko et al., 1998;
Flagg and Nichols, 2001; Lopatin and Nichols, 2001; Nerbonne
et al., 2001; Nerbonne, 2004). During postnatal development,
the APD shortens progressively as a result of the upregulation
of a number of potassium currents, both in the atria (Trepanier-
Boulay et al., 2004) and in the ventricles (Grandy et al., 2007).
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In the adult mouse heart, atrial and ventricular action poten-
tials are very similar in morphology [for a detailed review of all
underlying currents see Nerbonne (2004)].
Genetically engineered mice have revealed surprising contrib-
utors to the cardiac action potential. For example, deletion of the
calcium-activated potassium channel SK2 prolongs the APD in
atrial myocytes and leads to AF (Li et al., 2009), although SK
channels do not seem to contribute to the normal atrial action
potential in larger species (Nagy et al., 2009). SK channel function
may be affected by the tendency of SK subunits to form het-
eromers (Tuteja et al., 2010), and its functional contribution may
increase under pathological conditions, also in the ventricular
myocardium (Chua et al., 2011). In the mouse ventricles, deletion
of the “pacemaker current” HCN3 leads to an increase in T wave
amplitude due to an acceleration of the terminal repolarization in
epicardial myocytes (Fenske et al., 2011).
The main Ca2+ extrusion mechanism in cardiomyocytes is the
Na+/Ca2+ exchanger (NCX), which generates a net depolarizing
current due to its stoichiometry (Bers, 2002; Pott et al., 2004).
In most respects, mice overexpressing NCX and cardiac-specific
NCX knockouts show opposite cardiac phenotypes, although
cardiac hypertrophy was observed in both (Henderson et al.,
2004; Pott et al., 2004; Goldhaber et al., 2005; Reuter et al.,
2005; Pott et al., 2012). Due to the calcium-dependence of ICaL
inactivation, NCX overexpressing mice and cardiac-specific NCX
knockouts had accelerated and decelerated inactivation kinetics
of ICaL, respectively, leading to APD prolongation and shorten-
ing, respectively (Pott et al., 2004; Goldhaber et al., 2005; Reuter
et al., 2005; Pott et al., 2007). NCX overexpression increased
and cardiac-specific NCX deletion decreased vulnerability to
ischemia/reperfusion injury, supporting the role of calcium influx
through the reverse-mode NCX under these circumstances (Pott
et al., 2004; Imahashi et al., 2005). In hearts of larger mammals,
like dog, rabbit, and human, reuptake into the sarcoplasmic retic-
ulum and elimination by the NCX account for approx. 70% and
30% of Ca2+ removal, respectively, while in mice and rats up to
90% of Ca2+ is taken back up into the sarcoplasmic reticulum
(Bassani et al., 1994; Nishimaru et al., 2001). Under steady state
conditions (i.e., a stable diastolic SR calcium load), the amount
of calcium extruded by the sodium-calcium exchanger (NCX)
equals the amount of calcium entering through L-type calcium
channels. Increased NCX expression is thought to contribute to
arrhythmogenesis in failing human and rabbit hearts (Studer
et al., 1994; Lindner et al., 1998; Pieske et al., 1999; Pogwizd
et al., 1999, 2001; Schillinger et al., 2000), and EADs, DADs
and episodes of ventricular tachycardia were inducible in NCX-
overexpressing mice (Pott et al., 2012). Increased NCX expression
causes reduced twitch calcium transients and SR calcium load in
rabbit ventricles (Ranu et al., 2002). In contrast, increased NCX
expression in mice does not affect twitch Ca2+ transients and
SR calcium load (Adachi-Akahane et al., 1997; Terracciano et al.,
1998; Yao et al., 1998). This difference between mice and larger
mammals may be caused by a higher cytoplasmic sodium con-
centration ([Na]i] in murine myocytes (Shattock and Bers, 1989;
Yao et al., 1998; Despa et al., 2002), which would impair extrusion
via NCX (Bers, 2002). A negative force-frequency relationship
has been reported for murine ventricles, often with high Ca2+
concentration of the SR, even under low stimulation frequencies
(Bers, 2002). Again, the high [Na]i may impair Ca2+ extrusion via
NCX and explain why an increasing in heart rate hardly affects SR
calcium load in mice (Shattock and Bers, 1989; Yao et al., 1998).
In addition, refractoriness of excitation contraction coupling and
smaller fractional SR Ca2+ is observed during high heart rates
(Bers et al., 1993). Both mechanisms probably contribute to neg-
ative force-frequency relationship in mouse ventricular myocytes
(Bers, 2002).
CHANGES IN CARDIAC ELECTROPHYSIOLOGY IN MOUSE
MODELS OF HEART DISEASE
MYOCARDIAL INFARCTION
Mouse models of myocardial ischemia and infarction are com-
monly generated by ligation of the left anterior descending
coronary artery (LAD). Temporary ligation of the LAD with
subsequent reperfusion has been used as a model of ischemia-
reperfusion injury, allowing determination of the infarct size
in relation to the area at risk (Michael et al., 1995). In
Langendorff-perfused mouse hearts, regional ischemia and reper-
fusion increased the incidence of induced and spontaneous ven-
tricular tachycardia (VT) (Koyama et al., 2003; Inagaki et al.,
2005; Anzawa et al., 2006; Maass et al., 2009; He et al., 2012).
Depending on the exact inschemia-reperfusion protocol, ven-
tricular fibrillation (VF) may also be observed (Koyama et al.,
2003; Inagaki et al., 2005; He et al., 2012), especially when cate-
cholamines are added to the perfusate (Stables and Curtis, 2009).
In open-chest experiments, episodes of ventricular tachycardia
(VT) were observed both during regional ischemia and reperfu-
sion (Sakamoto et al., 1999; Anyukhovsky et al., 2011). Mice with
a permanent ligation of the LAD show infarct-related changes
in T-wave morphology, reduced cardiac function, and increased
inducibility of atrial and ventricular arrhythmias (Gehrmann
et al., 2001). In conscious mice with a myocardial infarction (MI),
telemetric monitoring revealed frequent premature ventricular
beats, but spontaneous VT episodes were rare (Betsuyaku et al.,
2004). Heart rate variability (HRV) a marker of autonomic ner-
vous system activity and a predictor of arrhythmias in human
MI patients, was not affected by MI in mice (Gehrmann et al.,
2001) Decreased HRV is thought to result from an enhanced sym-
pathetic and decreased parasympathetic activity, but in contrast
to humans, mice already show a predominant sympathetic tone,
since parasympathetic blockade does not increase in HR (Mansier
et al., 1996; Wickman et al., 1998) but sympathetic blockade
caused a pronounced decrease in HR (Janssen et al., 2000; Just
et al., 2000). For a detailed review on autonomic regulation of
cardiac function in mice, see (Janssen and Smits, 2002).
PRESSURE OVERLOAD
Transverse aortic constriction (TAC) by banding the proximal
aorta has become a standard method to generate chronic pres-
sure overload in mice, leading to LV hypertrophy with decreased
fractional shortening within 4–5 weeks (Hill et al., 2000). TAC
leads to an increase in QRS duration and a decrease in RV longi-
tudinal conduction velocity (Boulaksil et al., 2010). Furthermore,
these mice showed increased interstitial fibrosis and Cx43 het-
erogeneity (Boulaksil et al., 2010), and an increased inducibility
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of polymorphic ventricular tachyarrhythmias (Boulaksil et al.,
2010; Jansen et al., 2012; Vinet et al., 2012). The inducibility and
stability of atrial fibrillation also increase as a result of TAC (Liao
et al., 2010). In addition to the working myocardium, pressure
overload may also affect Cx and HCN expression in the ventricu-
lar conduction system and thereby alter the ventricular activation
pattern (Harris et al., 2012).
METHODS FOR STUDYING MURINE CARDIAC
ELECTROPHYSIOLOGY
Different mouse strains show considerable differences in baseline
electrocardiographic parameters (Wehrens et al., 2000; Waldeyer
et al., 2009) and in processes such as for example wound healing
after myocardial infarction (van den Borne et al., 2009), under-
scoring the importance of a homogeneous genetic background in
assessing the role of a genetically modified gene. Studying murine
cardiac physiology has required the miniaturization of instru-
ments and techniques originally developed for human studies.
This section will briefly outline a number of techniques that are
currently available.
SURFACE ELECTROCARDIOGRAMS
As shown in Figure 1, murine and human ECGs show some
salient differences that complicate comparison of ECGs from
both species (Sabir et al., 2008). In both species, the ECGs show
P waves, reflecting spread of atrial depolarization (Sabir et al.,
2008). Subsequently, both ECGs show an isoelectric PQ inter-
val that reflects impulse conduction from the atria through the
AV node and the His-Purkinje system to the ventricles (Schrickel
et al., 2002; Sabir et al., 2008). In mice and humans, the ensu-
ing QRS complex reflects ventricular depolarization (Schrickel
et al., 2002; Sabir et al., 2008). The normal murine ECG shows
a distinct J wave at the end of the QRS complex (Liu et al.,
2004). By contrast, the human ECG infrequently displays a slight
J wave, but it can become more prominent during hypothermia
(Osborn, 1953). Because of the triangular shape of the murine
ventricular action potential, with a gradual time course of repo-
larization, mouse ventricles do not have a distinct “moment of
repolarization.” As a result, the T wave in the murine ECG is
often poorly visible (Liu et al., 2004; Sabir et al., 2008). In some
murine studies, the QT interval was defined as the period between
the start of the Q wave to the point of return to the isoelectri-
cal line (Verheule et al., 1999; Schrickel et al., 2002). However,
correlation of monophasic action potential recordings with the
surface ECG indicates that the terminal repolarization of the ven-
tricles may extend into the subsequent P-wave (Danik et al., 2002;
Liu et al., 2004). The absence of a clear T wave impedes inves-
tigation of murine ventricular repolarization in the surface ECG
(Danik et al., 2002). Within the physiological range, the relative
degree of rate dependence of the ventricular APD is comparable
between mice and humans (Knollmann et al., 2007). The murine
QT interval can be corrected for heart rate using Bazett’s for-
mula, which is used in human ECG analysis, or (preferably) by
a related formula specifically modified for mice (Mitchell et al.,
1998).
Small implantable ECG transmitters permit investigation of
spontaneous arrhythmias in conscious mice during normal
physical activity and during short-term and long-term drug
application (Gehrmann and Berul, 2000; Gehrmann et al., 2000;
Fabritz et al., 2010). This technique also allows investigation of
acute and chronic exercise stress on arrhythmogenesis by using
standardized protocols such as e.g., swimming exercise (Berul,
2003; Fabritz et al., 2010). In determining the degree of exer-
cise, it should be take into account that mice will voluntary
run a respectable distance of 6 km per day (de Waard et al.,
2007).
PROGRAMMED ELECTRICAL STIMULATION IN INTACT MICE
In intact mice under anaesthesia, transesophageal catheters can
be used for programmed electrical stimulation of the atria for
arrhythmia induction and determination of sinus node recov-
ery time, AV nodal ERP and Wenckebach period (Schrickel et al.,
2002; Berul, 2003; Verheule et al., 2004). Due to the lack of direct
contact with the atrium and the distance between stimulation
poles, stimulus artefacts during transesophageal stimulation are
large, obscuring the atrial complex. Therefore, the atrial ERP can
not be determined reliably using this technique (Etzion et al.,
2008). Because transesophageal stimulation allows survival of the
animal, it can be used for longitudinal studies of cardiac electro-
physiology over a longer time period. The ventricles cannot be
paced using transesophageal stimulation, but Gutstein et al. have
presented amethod for subdiaphragmatic ventricular stimulation
that allows repeated studies in individual mice (Gutstein et al.,
2003).
Pacing (and recording) electrodes can be attached either epi-
cardially in open chest experiments (Berul et al., 1996; Verheule
et al., 1999) or endocardially using a transvenous access route
(VanderBrink et al., 1999; Saba et al., 2000). The latter also per-
mits the recording of his bundle potentials (VanderBrink et al.,
1999; Saba et al., 2000). Programmed electrical stimulation using
epi- or endocardial electrodes allows assessment of SA node
and AV node function, refractory periods, Wenckebach period-
icities and vulnerability to atrial and ventricular arrhythmias
(Gehrmann et al., 2000; Saba et al., 2000; Berul, 2003). Given the
small dimensions of themouse heart, close apposition of the poles
of the stimulation electrode is necessary to reduce stimulus arte-
facts and allow recording of local electrograms (Verheule et al.,
1999; Etzion et al., 2008).
MAPPING IN PERFUSEDMOUSE HEARTS
Isolated Langendorff perfused hearts allow detailed studies of
cardiac electrophysiology without neurohumoral and autonomic
influences, under artificial conditions that can easily be manip-
ulated. Perfused hearts allow pacing and recording of electro-
grams and monophasic action potentials (Fabritz et al., 2003;
Blana et al., 2010). In addition, the Langendorff setup offers the
opportunity to perform high-density epicardial mapping using
multi-electrode arrays to record activation patterns (van Rijen
et al., 2001; Verheule et al., 2004). Sampling frequency has to be
sufficiently high in mapping experiments. For example, with a
relatively simple 5 × 5 electrode array covering 2 × 2mm (about
the size of an atrial free wall), the inter-electrode distance would
be 0.4mm. Assuming a conduction velocity of 0.5 m/s, (Verheule
et al., 1999, 2004) the time difference between electrodes in the
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propagation direction would be 0.8ms. Accurate determination
of local conduction velocities would then require a sampling
frequency of at least 2.5 kHz (1/0.8 × 2).
With currently available technology, the highest spatio-
temporal resolution can be attained using optical mapping (up
to 100 × 100 pixels at a sampling rate of up to 10 kHz). Using
this technique, detailed activation mapping has been reported
in various mouse models (de Diego et al., 2008; Blana et al.,
2010; Lang et al., 2011). In addition, the acquired optical sig-
nals are linearly dependent on the transmembrane potential and
therefore represent an “ensemble action potential,” providing
information on the time course of repolarization and diastolic
intervals. Furthermore, activation patterns during arrhythmias,
e.g., rapid reentry, can be studied in detail (Vaidya et al.,
1999; Baudenbacher et al., 2008). However, to suppress motion
artefacts, most studies have used excitation-contraction uncou-
plers such as butadione monoxime, cytochalasin D or blebbis-
tatin, all of which can affect cardiac electrophysiology in mice.
2,3-Butadione monoxime (BDM) markedly shortens the APD
(Biermann et al., 1998). In mice, Cytochalasin D prolongs APD
and reduces CV (Baker et al., 2004). Blebbistatin has little effect
on the AP morphology, (Fedorov et al., 2007) but can sup-
press arrhythmias by inhibiting myofilament calcium sensitivity
(Baudenbacher et al., 2008).
THE ISSUE OF CARDIAC SIZE IN TACHY-ARRYTHMIAS
In 1914, Garrey postulated that a certain size of myocardial tis-
sue, a “critical mass,” is required to sustain reentrant arrhythmias
(Garrey, 1924). This led to the belief that the mouse heart would
be “too small to fibrillate.” This belief has been challenged by
murine studies showing atrial (Schrickel et al., 2002; Verheule
et al., 2004) and ventricular fibrillation (Vaidya et al., 1999).
Specific mouse models of atrial (Nattel et al., 2005; Schotten et al.,
2011) and ventricular (Sabir et al., 2008) arrhythmias have been
expertly reviewed elsewhere. Similarly, the general mechanisms
of atrial (Nattel et al., 2005; Schotten et al., 2011) and ventricular
(Antzelevitch, 2001) arrhythmias have been reviewed extensively.
Instead, this last section will discuss the general issue of cardiac
size in the context of arrhythmias. With respect to the propaga-
tion pattern, arrhythmias can be either “hierarchical,” with one
or more localized sources driving the arrhythmia or “anarchi-
cal” where no particular site is driving the arrhythmia. Whereas
the former is amenable to targeted ablation strategies, the latter
is not. With respect to the underlying mechanism, an arrhyth-
mia will be based on cellular proarrhythmic events giving rise
to premature, ectopic action potentials or on reentrant conduc-
tion (Antzelevitch, 2001; Sabir et al., 2008). Regardless of the
system of classifying arrhythmias, in all cases the size of the sub-
strate is likely to affect the initiation, stability and pattern of the
arrhythmia, as discussed below.
REENTRY
The simplest form of reentry is a single reentrant wave circling
around an anatomic obstacle or area of functional block. The
“wavelength” of such a wave is the product of CV and ERP.
(Wiener and Rosenblueth, 1946) With the normal CV and ERP in
the mouse heart, this wavelength (WL) would be approximately
FIGURE 2 | Scaling of atrial electrophysiology to body mass. Upper
panel: atrial action potentials in various species (Schotten et al., 2011).
Middle row, left panel: atrial ERP as a function of body mass (mouse
Verheule et al., 1999, rat Chang et al., 2002, rabbit Fedorov et al., 2007, dog
Fareh et al., 1998, goat Blaauw et al., 2004, human Roberts-Thomson et al.,
2009, horse Van Loon et al., 2002). Middle row, right panel: atrial CV as a
function of body mass [mouse Leaf et al., 2008, rat Haugan et al., 2005,
rabbit de Groot et al., 2003, dog Fareh et al., 1998, goat Verheule et al.,
2010, human Hansson et al., 1998, horse (NA)]. Bottom row, left panel:
wavelength (product of CV and ERP) as a function of body mass. Bottom
row, right panel: ratio of atrial circumference to wavelength. The atrial
circumference was calculated by taking the LA diameter and approximating
the total circumference as 2∗2∗π∗LA radius (mouse Blana et al., 2010, rat
Boixel et al., 2003, rabbit Hirose et al., 2005, dog Stepien et al., 1998, goat
Wijffels et al., 1997, human Monnig et al., 2005, horse Menzies-Gow et al.,
2005). Interestingly, the number of reentrant waves that can fit on the atrial
circumference does not scale strongly with the body mass.
1.2 cm in for the atrium, close to the normal estimated atrial
circumference (Figure 2). However, this same argument holds
true for larger species, as the ratio between estimated atrial
circumference to WL is almost completely independent of body
mass (Figure 2). According to the WL theory, a decrease in CV
or ERP would make reentry more likely. Indeed, shortening the
ERP by applying acetylcholine increases AF stability in mice, as
it does in larger species (Kovoor et al., 2001; Wakimoto et al.,
2001).
A shorterWLwould also allowmore fibrillationwaves to prop-
agate simultaneously within the atria or ventricles. According
to the “multiple wavelet theory,” fibrillation can persist with-
out any particular site or circuit dominating the arrhythmia, as
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long as a sufficiently large number of irregularly propagating
fibrillation waves can coexist within a substrate (Allessie, 1998).
The likelihood of multiple wavelet reentry increases when WL
becomes smaller (Rensma et al., 1988; Allessie et al., 1996).
However, several studies have shown that structural inhomo-
geneities can lead to “zig-zag” conduction, allowing “microreen-
try” to occur in much smaller circuits than would be expected
based on calculation of the macroscopically determined WL (de
Bakker et al., 1993; Spach and Josephson, 1994; Koura et al.,
2002). To date, there is no direct evidence that “anarchical”multi-
ple wavelet reentry can occur inmouse hearts. The small substrate
size represented by the mouse heart may limit the number of
coexisting fibrillation waves and thusmakemultiple wavelet reen-
try less likely. For example, the degree of fibrosis necessary to
create a substrate for multiple wavelet reentry in a mouse heart
may have to be larger than that required in a larger heart. AF sta-
bility was indeed greatly increased in a mouse model of selective
atrial fibrosis (Verheule et al., 2004), but fibrillatory conduction in
this model may be based on triggered activity rather thanmultiple
wavelet reentry (Choi et al., 2012).
Spiral wave reentry is a specific form of reentry that has been
described mathematically and observed experimentally in several
types of excitable media (Jalife et al., 2002; Comtois et al., 2005).
Vaidya et al. demonstrated sustained spiral wave reentry around a
single core in murine ventricles with a period of wavefront rota-
tion of 72ms and frequency of 14Hz (Vaidya et al., 1999). This
study also detected figure-of-8 reentry with a rotation period of
66ms, demonstrating that the murine ventricle is able to sustain
two stable reentrant waves (Vaidya et al., 1999). It is important to
note that calculated wavelengths in this study were much larger
than size of the mouse heart and that APD showed almost no fre-
quency dependence (Vaidya et al., 1999). Computer simulations
suggested that the core during vortex reentry altered repolariza-
tion in adjacent myocardium, leading to reduced APDs near the
core and longer APDs at larger distance to the core (Beaumont
et al., 1998). This hypothesis was supported by the observation
that during occurrence of spiral wave reentry, the average APD
of the entire preparation was reduced and that pacing at the fre-
quency of the spiral wave produced longer APDs (Vaidya et al.,
1999). Thus, wavelength calculations based on external electrical
stimulation probably have a poor predictive value for genera-
tion and maintenance of spiral wave reentry in the murine heart
(Vaidya et al., 1999).
Studies in mammalian species from mouse to horse show
scaling of VF frequency with BM, following the equation
VFfrequency = 18.9 × BM−1/4 (Noujaim et al., 2007). Noujaim
et al. demonstrated stable VF with vortex-like reentry and high-
est dominant frequency (DF) in the mouse heart with 38Hz and
reduction of DF with growing BM, as reflected by a DF of 6.8Hz
in the human heart (Noujaim et al., 2007). However, in larger
mammalian hearts, the rapid activity of a rotor in one region
does not conduct in a 1:1 fashion to the rest of the substrate. In
most cases, and certainly within the complex anatomy of the atria,
the waves emanating from that “mother” rotor will break up and
spin off “daughter” wavelets to the rest of the atrium (Chen et al.,
2000). Thus, the overall conduction pattern will be characterized
by interaction of the rotor and fibrillatory waves in the rest of the
substrate. When a rotor is present in a relatively small medium,
the interaction between the rotor and the rest of the substrate is
therefore likely to be different (Zou et al., 2005).
ECTOPIC ACTIVITY
Cellular proarrhythmic events can give rise to ectopic activ-
ity. Accelerated diastolic depolarization of myocytes with pace-
maker activity can cause a latent pacemaker region to act as
an ectopic focus (enhanced automaticity). By contrast, triggered
activity results from “afterdepolarizations” triggered by a nor-
mal action potential. Early afterdepolarizations (EADs) develop
during phase 2–3 of the AP and are precipitated by a prolonged
APD during which the L-type Ca2+ channels recover and switch
from the inactivated to the open state to produce a depolarizing
current (Sabir et al., 2008). Delayed afterdepolarizations (DADs)
occur during phase 4 of the AP in situations of intracellular Ca2+
overload, evoked by e.g., beta-adrenergic stimulation, ischemia,
and hypokalaemia. In this case, the excess of intracellular Ca2+ is
transported by the NCX, causing a depolarizing current (Schotten
et al., 2011). As discussed in section III, to function at high heart
rates, mouse myocytes have a short action potential and some dif-
ferences in calcium handling compared to myocytes from larger
mammalian hearts, and these factors may affect the generation of
EADs andDADs. Nevertheless, several mouse models have shown
arrhythmias initiated by afterdepolarizations (see e.g., Fabritz
et al., 2003; Killeen et al., 2007a; Choi et al., 2012; Li et al., 2012;
Pott et al., 2012).
Regardless of its exact nature (diastolic depolarization, early or
delayed after depolarization), a proarrhythmic mechanism active
in a single myocyte is unlikely to lead to a propagated response in
the intact tissue, because the current generated by that myocyte
will leak away to its neighbors without reaching the action poten-
tial threshold. Thus, the occurrence of a proarrhythmic event will
have to be synchronized in a sufficiently large group of myocytes
in order to reach the threshold and be able to propagate away from
that area. This holds true both for an ectopic pacemaker region
(Joyner et al., 2000) and for an area displaying triggered activity
(Sato et al., 2009). Does an ectopic focus in a mouse heart have
to same relative size to the rest of the heart as a focus in larger
mammals? Mouse ventricular myocytes (90μm in length, 14μm
in diameter) (Toischer et al., 2010) are smaller than dog myocytes
(130μm in length, 30μm in diameter) (Clemo et al., 1998).
Assumingmyocytes to be roughly cylindrical, this would translate
to a ratio of 8:1 in myocyte volume between dogs andmice. While
considerable, this ratio is much smaller than the 1100:1 ratio in
ventricular weight (or volume) between these species (Bienvenu
and Drolet, 1991), implying that the mouse ventricle contains far
fewer myocytes (by about a factor 150 in this crude estimate). No
direct measurements of electrotonic interactions in mouse ven-
tricles are available, but at 0.6 m/s, the conduction velocity in
mouse ventricles is close to that in larger species, suggesting that
electrotonic interactions are comparable (Gutstein et al., 2001).
These indirect arguments would indicate that an ectopic focus
in mouse ventricles may not be much smaller than that in larger
hearts, and would thus occupy a relatively larger area of the heart.
During rapid focal activity, this size-relation would affect the pat-
tern of fibrillation (i.e., wavebreak). In addition, the small size of
the mouse heart would limit the number of localized arrhyth-
mogenic sources that can coexist. Propagation from an ectopic
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focus is most likely when electrical coupling gradually increases
from the focus to the surrounding muscle, because a high degree
of electrical coupling would effectively silence the focus (Joyner
et al., 2007). Thus, structural remodeling (e.g., fibrosis) would
allow a smaller focus to successfully conduct its rapid rate to the
rest of the heart.
Apart from the role of cardiac size, various other caveats apply
to extrapolation of arrhythmias in mouse models to clinically
observed human arrhythmias. A very high degree of overexpres-
sion or underexpression of a particular gene may lead to indirect
alterations that would not be observed as a result of more mod-
erately altered expression of that gene in human pathology. In
addition, overexpression or deletion of a gene during the pre-
natal period may lead to a disruption of cardiac development
and result in secondary changes that do not reflect the role of
that gene in the adult human heart. All cautionary considera-
tions notwithstanding, mouse models have displayed numerous
types of arrhythmias that bear a striking electrocardiographic
resemblance to human arrhythmias. These include various tach-
yarrhythmias such as atrial flutter (Zhang et al., 2005), atrial
fibrillation (Verheule et al., 2004), (polymorphic) ventricular
tachycardia (Fabritz et al., 2003; van Rijen et al., 2004; Cerrone
et al., 2007) and ventricular fibrillation (Cerrone et al., 2005),
bradyarrhythmias such as sinus bradycardia (Lei et al., 2005)
and conduction disorders such as AV block (Zhang et al., 2011),
bundle branch block (van Rijen et al., 2001), accessory atrioven-
tricular pathways (Arad et al., 2003) and long QT (Salama and
London, 2007; Ruan et al., 2009; Sanguinetti, 2010) and Brugada
(Martin et al., 2010) syndromes.
CONCLUSIONS
Over the last two decades, mice have become a widely used
model instrument in research into cardiac arrhythmias. Progress
in miniaturization of techniques has allowed detailed studies
of electrophysiological parameters of the murine heart. Genetic
engineering has allowed the generation of mouse models carry-
ing humanmutations that cause arrhythmias and has contributed
to understanding the role of specific genes, proteins and ionic
channels in arrhythmogenesis. In general, mouse models have
broadened our knowledge of cardiac electrophysiology andmech-
anisms underlying atrial and ventricular arrhythmias in humans.
Mouse models can mimic human cardiac arrhythmias despite
differences in cardiac electrophysiology. However, some mecha-
nisms of arrhythmias in mice may differ from those in humans
and therefore have to be extrapolated to the human situation with
caution.
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